Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy

NCT02911025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2021-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to monitor the effect of Clobazam on sleep and daytime alertness in people with Epilepsy.

Conditions

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Milena Pavlova, MD · Brigham and Women's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911025 on ClinicalTrials.gov